Selected biotech news
The London Stock Exchange censured the drug development company, British Biotech, after completing a 15 month investigation which concluded that the company had violated exchange rules. The exchange said British Biotech had failed to disclose information which could impact on its business and move its share prices between June 1997...
Comment
We must allow therapeutic applications of cloning
by Dr John Gillott
It was against the background of increasing excitement about the therapeutic potential of stem-cell and cloning technologies that the UK Government's Human Genetics Advisory Commission and the Human Fertilisation and Embryology Authority issued a joint report last December. They strongly recommended that the Government give the go-ahead for research using...